562 related articles for article (PubMed ID: 18425487)
1. Maldi-TOF mass spectrometry for analyzing cell-free fetal DNA in maternal plasma.
Ding C
Methods Mol Biol; 2008; 444():253-67. PubMed ID: 18425487
[TBL] [Abstract][Full Text] [Related]
2. Size fractionation of cell-free DNA in maternal plasma and its application in noninvasive detection of fetal single gene point mutations.
Li Y; Holzgreve W; Hahn S
Methods Mol Biol; 2008; 444():239-51. PubMed ID: 18425486
[TBL] [Abstract][Full Text] [Related]
3. Qualitative and quantitative DNA and RNA analysis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Ding C
Methods Mol Biol; 2006; 336():59-71. PubMed ID: 16916253
[TBL] [Abstract][Full Text] [Related]
4. Recent developments in fetal nucleic acids in maternal plasma: implications to noninvasive prenatal fetal blood group genotyping.
Lo YM
Transfus Clin Biol; 2006; 13(1-2):50-2. PubMed ID: 16563836
[TBL] [Abstract][Full Text] [Related]
5. Size fractionation of cell-free DNA in maternal plasma improves the detection of a paternally inherited beta-thalassemia point mutation by MALDI-TOF mass spectrometry.
Li Y; Di Naro E; Vitucci A; Grill S; Zhong XY; Holzgreve W; Hahn S
Fetal Diagn Ther; 2009; 25(2):246-9. PubMed ID: 19506384
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive prenatal detection of achondroplasia in size-fractionated cell-free DNA by MALDI-TOF MS assay.
Li Y; Page-Christiaens GC; Gille JJ; Holzgreve W; Hahn S
Prenat Diagn; 2007 Jan; 27(1):11-7. PubMed ID: 17154237
[TBL] [Abstract][Full Text] [Related]
7. Genotyping fetal paternally inherited SNPs by MALDI-TOF MS using cell-free fetal DNA in maternal plasma: influence of size fractionation.
Li Y; Wenzel F; Holzgreve W; Hahn S
Electrophoresis; 2006 Oct; 27(19):3889-96. PubMed ID: 16972300
[TBL] [Abstract][Full Text] [Related]
8. Recent developments in the detection of fetal single gene differences in maternal plasma and the role of size fractionation.
Li Y; Hahn S; Holzgreve W
Ann N Y Acad Sci; 2006 Dec; 1092():285-92. PubMed ID: 17308152
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive genotyping fetal Kell blood group (KEL1) using cell-free fetal DNA in maternal plasma by MALDI-TOF mass spectrometry.
Li Y; Finning K; Daniels G; Hahn S; Zhong X; Holzgreve W
Prenat Diagn; 2008 Mar; 28(3):203-8. PubMed ID: 18241084
[TBL] [Abstract][Full Text] [Related]
10. Detection and quantification of fetal DNA in maternal plasma by using LightCycler technology.
Purwosunu Y; Sekizawa A; Okai T
Methods Mol Biol; 2008; 444():231-8. PubMed ID: 18425485
[TBL] [Abstract][Full Text] [Related]
11. Quantification of circulatory fetal DNA in the plasma of pregnant women.
Zimmermann BG; Maddocks DG; Avent ND
Methods Mol Biol; 2008; 444():219-29. PubMed ID: 18425484
[TBL] [Abstract][Full Text] [Related]
12. High-throughput multiplex SNP genotyping with MALDI-TOF mass spectrometry: practice, problems and promise.
Bray MS; Boerwinkle E; Doris PA
Hum Mutat; 2001 Apr; 17(4):296-304. PubMed ID: 11295828
[TBL] [Abstract][Full Text] [Related]
13. Analysis of single nucleotide polymorphisms by primer extension and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Fei Z; Smith LM
Rapid Commun Mass Spectrom; 2000; 14(11):950-9. PubMed ID: 10844731
[TBL] [Abstract][Full Text] [Related]
14. High-throughput alternative splicing quantification by primer extension and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
McCullough RM; Cantor CR; Ding C
Nucleic Acids Res; 2005 Jun; 33(11):e99. PubMed ID: 15967806
[TBL] [Abstract][Full Text] [Related]
15. Feasibility study of using fetal DNA in maternal plasma for non-invasive prenatal diagnosis.
Liu FM; Wang XY; Feng X; Wang W; Ye YX; Chen H
Acta Obstet Gynecol Scand; 2007; 86(5):535-41. PubMed ID: 17464580
[TBL] [Abstract][Full Text] [Related]
16. A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.
Bauer M; Hutterer G; Eder M; Majer S; Leshane E; Johnson KL; Peter I; Bianchi DW; Pertl B
Prenat Diagn; 2006 Sep; 26(9):831-6. PubMed ID: 16832830
[TBL] [Abstract][Full Text] [Related]
17. Advances in the research of fetal DNA in maternal plasma for noninvasive prenatal diagnostics.
Vlková B; Szemes T; Minárik G; Turna J; Celec P
Med Sci Monit; 2010 Apr; 16(4):RA85-91. PubMed ID: 20357733
[TBL] [Abstract][Full Text] [Related]
18. Prenatal detection of beta-thalassemia CD17 (A-->T) mutation by polymerase chain reaction/ligase detection reaction/capillary electrophoresis for fetal DNA in maternal plasma--a case report.
Yi P; Chen Z; Yu L; Zheng Y; Xie H; Zheng X; Liu Q; Han J; Li L
Fetal Diagn Ther; 2010; 27(1):25-31. PubMed ID: 19955703
[TBL] [Abstract][Full Text] [Related]
19. RHD genotyping from maternal plasma: guidelines and technical challenges.
Avent ND
Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
[TBL] [Abstract][Full Text] [Related]
20. Isolation of cell-free DNA from maternal plasma using manual and automated systems.
Huang DJ; Mergenthaler-Gatfield S; Hahn S; Holzgreve W; Zhong XY
Methods Mol Biol; 2008; 444():203-8. PubMed ID: 18425482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
